Postprandial glucose incremental peak rise: molecular mechanisms & dependencies

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

Human evidence only

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

Most of the 16 human intervention studies considered pertinent for the scientific substantiation of the claim showed that oat beta-glucans reduce postprandial blood glucose peaks when consumed as part of foods or meals rich in available carbohydrates, the Panel also took into account that oat beta-glucans did not increase postprandial glycaemic or insulinaemic responses and that the mechanism by which consumption could exert the claimed effect is well established, and the Panel concludes that a cause-and-effect relationship has been established, with foods or meals required to contain at least 30 grams of available carbohydrates per portion and at least 3 grams of beta-glucans from oats for each 30 grams of available carbohydrates in order to bear the claim.
Oat mixed-linkage beta-(1->3)/(1->4)-glucan → Postprandial glucose incremental peak rise source_derived_draftungraded
Experimental context and source evidence
evidence_span
{"source_cache": "artifacts/glucan-research/41726114.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "22ad4a8c479116e3d7130ddcda6f561239dc9b2048d52e29279e48bac6799a3e", "start_char": 0, "end_char": 1617, "text_sha256": "22ad4a8c479116e3d7130ddcda6f561239dc9b2048d52e29279e48bac6799a3e"}
experimental_model
European Food Safety Authority assessment of 16 human intervention studies for a new health claim
exposure
Oat beta-glucans consumed as part of foods or meals rich in available carbohydrates
limitations
A regulatory opinion that weighs an evidence base and sets conditions of use. Authorisation is a separate legal step, and the claim applies only under the stated conditions.
nutrient_topic
Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. · Beta-glucan
organism
Human
plain_language
A regulator accepted the effect on the glucose peak, and attached an exact amount and an exact kind of meal to it.
primary_references
[bg-p41726114] Oat beta-glucans and reduction of postprandial glucose peak: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. (2026). https://pubmed.ncbi.nlm.nih.gov/41726114/ DOI: 10.2903/j.efsa.2026.9942
tissue_or_cell_type
Postprandial circulation
Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22) · lines 606–617
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · European Food Safety Authority assessment of 16 human intervention studies for a new health claim · source_derived_draft · unverified_draft
### bg-a-claim-with-conditions Most of the 16 human intervention studies considered pertinent for the scientific substantiation of the claim showed that oat beta-glucans reduce postprandial blood glucose peaks when consumed as part of foods or meals rich in available carbohydrates, the Panel also took into account that oat beta-glucans did not increase postprandial glycaemic or insulinaemic responses and that the mechanism by which consumption could exert the claimed effect is well established, and the Panel concludes that a cause-and-effect relationship has been established, with foods or meals required to contain at least 30 grams of available carbohydrates per portion and at least 3 grams of beta-glucans from oats for each 30 grams of available carbohydrates in order to bear the claim. Condition category: normal nutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. plain_language: A regulator accepted the effect on the glucose peak, and attached an exact amount and an exact kind of meal to it. organism: Human tissue_or_cell_type: Postprandial circulation experimental_model: European Food Safety Authority assessment of 16 human intervention studies for a new health claim limitations: A regulatory opinion that weighs an evidence base and sets conditions of use. Authorisation is a separate legal step, and the claim applies only under the stated conditions. exposure: Oat beta-glucans consumed as part of foods or meals rich in available carbohydrates evidence_span: {"source_cache": "artifacts/glucan-research/41726114.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "22ad4a8c479116e3d7130ddcda6f561239dc9b2048d52e29279e48bac6799a3e", "start_char": 0, "end_char": 1617, "text_sha256": "22ad4a8c479116e3d7130ddcda6f561239dc9b2048d52e29279e48bac6799a3e"} [bg-p41726114] Oat beta-glucans and reduction of postprandial glucose peak: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. (2026). https://pubmed.ncbi.nlm.nih.gov/41726114/ DOI: 10.2903/j.efsa.2026.9942
Complete structured claim and evidence

Where it participates (unsigned role)

Oat beta-glucan reduced glucose incremental area under the curve and incremental peak rise by 23% and 28% and insulin by 22% and 24% respectively, dose, molecular weight and comparator were significant effect modifiers of glucose incremental area under the curve and peak, significant linear dose-response relationships were observed for all outcomes, oat beta-glucan molecular weight above 300 kg/mol significantly reduced glucose measures whereas molecular weight below 300 kg/mol did not, outcomes were similar in participants with and without diabetes, and all outcomes had high certainty of evidence.
Oat mixed-linkage beta-(1->3)/(1->4)-glucan → Postprandial glucose incremental area under the curve source_derived_draftungraded
Experimental context and source evidence
evidence_span
{"source_cache": "artifacts/glucan-research/33608654.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "676672cfbc790125f3f39b9afbaa9211422f6ba82c3dc394c816268de96002c7", "start_char": 0, "end_char": 1872, "text_sha256": "676672cfbc790125f3f39b9afbaa9211422f6ba82c3dc394c816268de96002c7"}
experimental_model
Systematic review and meta-analysis of 103 acute crossover trial comparisons in 538 participants
exposure
Oat beta-glucan concentrate or oat bran added to carbohydrate-containing test meals against carbohydrate-matched controls
limitations
Acute meal responses with high certainty of evidence by GRADE. The magnitude depends on dose, molecular weight and which control meal is used, so a pooled percentage is not a prediction for any particular food.
nutrient_topic
Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. · Beta-glucan
organism
Human
plain_language
Adding it to a meal takes about a quarter off the glucose rise, but only if the polymer is long enough.
primary_references
[bg-p33608654] The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis. (2021). https://pubmed.ncbi.nlm.nih.gov/33608654/ DOI: 10.1038/s41430-021-00875-9
tissue_or_cell_type
Postprandial glucose and insulin
Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22) · lines 567–578
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Systematic review and meta-analysis of 103 acute crossover trial comparisons in 538 participants · source_derived_draft · unverified_draft
### bg-acute-glycaemic-response-falls Oat beta-glucan reduced glucose incremental area under the curve and incremental peak rise by 23% and 28% and insulin by 22% and 24% respectively, dose, molecular weight and comparator were significant effect modifiers of glucose incremental area under the curve and peak, significant linear dose-response relationships were observed for all outcomes, oat beta-glucan molecular weight above 300 kg/mol significantly reduced glucose measures whereas molecular weight below 300 kg/mol did not, outcomes were similar in participants with and without diabetes, and all outcomes had high certainty of evidence. Condition category: normal nutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair. plain_language: Adding it to a meal takes about a quarter off the glucose rise, but only if the polymer is long enough. organism: Human tissue_or_cell_type: Postprandial glucose and insulin experimental_model: Systematic review and meta-analysis of 103 acute crossover trial comparisons in 538 participants limitations: Acute meal responses with high certainty of evidence by GRADE. The magnitude depends on dose, molecular weight and which control meal is used, so a pooled percentage is not a prediction for any particular food. exposure: Oat beta-glucan concentrate or oat bran added to carbohydrate-containing test meals against carbohydrate-matched controls evidence_span: {"source_cache": "artifacts/glucan-research/33608654.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "676672cfbc790125f3f39b9afbaa9211422f6ba82c3dc394c816268de96002c7", "start_char": 0, "end_char": 1872, "text_sha256": "676672cfbc790125f3f39b9afbaa9211422f6ba82c3dc394c816268de96002c7"} [bg-p33608654] The effect of oat β-glucan on postprandial blood glucose and insulin responses: a systematic review and meta-analysis. (2021). https://pubmed.ncbi.nlm.nih.gov/33608654/ DOI: 10.1038/s41430-021-00875-9
Complete structured claim and evidence

The events it takes part in

A mechanism often involves more than two components. These are the full events, with every participant and its role.

Situations it appears in

Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

Open hypotheses

Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.

This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

Postprandial glucose incremental peak rise